Molecular Mechanisms of Bone Metastasis and Therapeutic Implications
- 1 October 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 415, S100-S104
- https://doi.org/10.1097/01.blo.0000093847.72468.2f
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Clinical relevance of increased retinoid and cAMP transcriptional programs in tumor cells rendered non-malignant by dominant negative inhibition of NFκBCancer Letters, 2003
- Expression of Vascular Endothelial Growth Factor D Is Associated with Lymph Node Metastasis in Human Colorectal CarcinomaOncology, 2003
- Bone cancer painCancer, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Malignant reversion of a human osteosarcoma cell line, Saos-2, by inhibition of NFκBBiochemical and Biophysical Research Communications, 2002
- Synergism of Aminobisphosphonates and Farnesyl Transferase Inhibitors on Tumor MetastasisPublished by Wolters Kluwer Health ,2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Tumor Necrosis Factor-α and -β Upregulate the Levels of Osteoprotegerin mRNA in Human Osteosarcoma MG-63 CellsBiochemical and Biophysical Research Communications, 1998
- Regulation of Osteoprotegerin mRNA Levels by Prostaglandin E2in Human Bone Marrow Stroma CellsBiochemical and Biophysical Research Communications, 1998
- CD44 and CD44v6 downregulation in clinical prostatic carcinoma: Relation to Gleason grade and cytoarchitectureThe Prostate, 1998